Sarah Hein, PhD, the chief executive officer and cofounder of March Biosciences, discussed the company’s trial design presentation at ASCO’s 2025 meeting.
Sarah Hein, PhD
Advertisement
The chief executive officer and cofounder of March Biosciences
Articles by Sarah Hein, PhD
The chief executive officer and cofounder of March Biosciences discussed the company’s trial design presentation at ASCO’s 2025 meeting.
Advertisement
Latest Updated Articles
The Phase 2 Trial for CD5-Directed CAR-T MB-105 in R/R T-Cell LymphomaPublished: May 31st 2025 | Updated:
Sarah Hein, PhD, on the Phase 2 Trial for CD5-Directed CAR-T MB-105 in R/R T-Cell LymphomaPublished: May 30th 2025 | Updated:
Advertisement
Advertisement
